NCT04481750View on ClinicalTrials.gov

Study of Oral Edaravone in Healthy Adult Males

PHASE1CompletedINTERVENTIONAL
Enrollment

74

Participants

Timeline

Start Date

March 20, 2018

Primary Completion Date

August 3, 2018

Study Completion Date

August 3, 2018

Conditions
Healthy Adult Subjects
Interventions
DRUG

MT-1186

Solution or suspension

DRUG

MT-1186-matching placebo

Solution or suspension

Trial Locations (1)

Unknown

Investigational Site, Osaka

Sponsors
All Listed Sponsors
lead

Mitsubishi Tanabe Pharma Corporation

INDUSTRY